Prospective, non-interventional study on the influence of adherence measures on the therapy with abiraterone acetate (AA) + prednisone/prednisolone (P) in patients with metastatic, castration resistant prostate carcinoma
| Autor: | Natasha Schuier, Tim Mathes, Andreas Huebner, Jochen Gleissner, Werner Baurecht, Henrik Suttmann, Susan Feyerabend, Edmund Neugebauer |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Androgen biosynthesis
Oncology Cancer Research medicine.medical_specialty business.industry Cancer drugs Abiraterone acetate Castration-Resistant Prostate Carcinoma chemistry.chemical_compound chemistry Prednisone Internal medicine Non interventional Prednisolone medicine In patient business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 34:e16525-e16525 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2016.34.15_suppl.e16525 |
| Popis: | e16525Background: AA is a blocker of androgen biosynthesis, which is highly effective in men with mCRPC in prolonging PFS and OS. Oncology experiences an increase in oral cancer drugs treatments, f... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|